Fundraising FoxIntuitive Ventures — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Cellares develops automated manufacturing systems and technology platforms to accelerate the production and commercialization of cell therapies.
Advanced ManufacturingBiotechMedical DevicesSouth San Francisco, US
Fabian Gerlinghaus(Co-Founder & CEO)inOmar Kurdi(Co-Founder & President)inAlex Pesch(Founder)Fabian Gerlinghaus Omar Kurdi(Founder)
BoardJustin Butler(Director)inVictor Tong(Director)in
Co-investorsDecheng Capital8VCEcoR1 CapitalKoch Disruptive TechnologiesBaillie GiffordBlackRock+4 more
Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes.
Digital HealthHealthtechMedical DevicesMinneapolis, US
Stacey Pugh(Leadership (CEO))inChris Sorli, MD, PhD(Chief Medical Officer)inKrissy Wright(Chief Financial Officer)inLian Cunningham, MD, PhD(VP Clinical Affairs)inMelanie Hess(Regulatory Affairs Leadership)inMatt Cambronne(Technical/Engineering Leadership)in
Co-investorsArboretum VenturesHatteras Venture PartnersLongitude CapitalLumira VenturesSoutheast Minnesota Capital Fund
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in
Co-investors8VCAlumni VenturesBeringeaGreat North VenturesiSelect FundLightbank+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.